Literature DB >> 11356638

NHE and ICAM-1 expression in hypoxic/reoxygenated coronary microvascular endothelial cells.

R Hattori1, H Otani, Y Moriguchi, H Matsubara, T Yamamura, Y Nakao, H Omiya, M Osako, H Imamura.   

Abstract

Although Na+/H+ exchange (NHE) has been implicated in myocardial reperfusion injury, participation of coronary microvascular endothelial cells (CMECs) in this pathogenesis has been poorly understood. NHE-induced intracellular Ca2+ concentration ([Ca2+]i) overload in CMECs may increase the synthesis of intercellular adhesion molecules (ICAM), which is potentially involved in myocardial reperfusion injury. The present study tested the hypothesis that NHE plays a crucial role in [Ca2+]i overload and ICAM-1 synthesis in CMECs. Primary cultures of CMECs isolated from adult rat hearts were subjected to acidic hypoxia for 30 min followed by reoxygenation. Two structurally distinct NHE inhibitors, cariporide and 5-(N-N-dimethyl)-amiloride (DMA), had no significant effect on the acidic hypoxia-induced decrease in intracellular pH (pH(i)) of CMECs but significantly retarded pH(i) recovery after reoxygenation. These NHE inhibitors abolished the hypoxia- and reoxygenation-induced increase in [Ca2+]i. Expression of ICAM-1 mRNA was markedly increased in the vehicle-treated CMECs 3 h after reoxygenation, and this was significantly inhibited by treatment with cariporide, DMA, or Ca2+-free buffer. In addition, enhanced ICAM-I protein expression on the cell surface of CMECs 8 h after reoxygenation was attenuated by treatment with cariporide, DMA, or Ca2+-free buffer. These results suggest that NHE plays a crucial role in the rise of [Ca2+]i and ICAM-1 expression during acidic hypoxia/reoxygenation in CMECs. We propose that inhibition of ICAM-1 expression in CMECs may represent a novel mechanism of action of NHE inhibitors against ischemia-reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356638     DOI: 10.1152/ajpheart.2001.280.6.H2796

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

1.  Exocytosis of IgG as mediated by the receptor, FcRn: an analysis at the single-molecule level.

Authors:  Raimund J Ober; Cruz Martinez; Xuming Lai; Jinchun Zhou; E Sally Ward
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-16       Impact factor: 11.205

Review 2.  Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn.

Authors:  E Sally Ward; Raimund J Ober
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

3.  Inhibition of Na+-H+ exchange by cariporide reduces inflammation and heart failure in rabbits with myocardial infarction.

Authors:  Katrin Rungwerth; Ursula Schindler; Martin Gerl; Stefan Schäfer; Thomas Licher; Andreas E Busch; Hartmut Ruetten
Journal:  Br J Pharmacol       Date:  2004-07-05       Impact factor: 8.739

4.  Sodium/hydrogen exchange inhibition with cariporide reduces leukocyte adhesion via P-selectin suppression during inflammation.

Authors:  U Buerke; D Pruefer; J M Carter; M Russ; A Schlitt; R Prondzinsky; J Makowski; S Rohrbach; B Niemann; C Schulze; M Dahm; C-F Vahl; K Werdan; M Buerke
Journal:  Br J Pharmacol       Date:  2008-03-10       Impact factor: 8.739

5.  Phospholipid scramblase 1 is required for β2-glycoprotein I binding in hypoxia and reoxygenation-induced endothelial inflammation.

Authors:  Emily Archer Slone; Michael R Pope; Sherry D Fleming
Journal:  J Leukoc Biol       Date:  2015-07-27       Impact factor: 4.962

6.  Cardioprotective efficacy of zoniporide, a potent and selective inhibitor of Na+/H+ exchanger isoform 1, in an experimental model of cardiopulmonary bypass.

Authors:  Hugh Clements-Jewery; Fiona J Sutherland; Mary C Allen; W Ross Tracey; Metin Avkiran
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

7.  Endothelial Na+/H+ exchanger NHE1 participates in redox-sensitive leukocyte recruitment triggered by methylglyoxal.

Authors:  Syed M Qadri; Yang Su; Francisco S Cayabyab; Lixin Liu
Journal:  Cardiovasc Diabetol       Date:  2014-09-30       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.